BioLineRx Ltd. (BLRX)
0.10
-0.01 (-8.76%)
At close: Jan 29, 2025, 3:59 PM
0.10
0.67%
After-hours Jan 29, 2025, 07:48 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
| Net Income | -60.61M | -24.95M | -27.05M | -30.02M | -25.45M | -22.96M | -24.35M | -15.84M | -14.40M | -10.17M | -17.64M | -20.42M | -13.19M | 2.10M |
| Depreciation & Amortization | 1.38M | 654.00K | 703.00K | 934.00K | 940.00K | 545.00K | 481.00K | 482.00K | 441.00K | 246.54K | 329.36K | 407.93K | 410.67K | 511.27K |
| Stock-Based Compensation | 2.32M | 2.25M | 1.50M | 1.27M | 1.76M | 2.53M | 1.51M | 1.07M | 1.15M | 968.69K | 872.94K | 839.95K | 1.05M | 1.85M |
| Other Working Capital | 12.96M | -650.00K | 24.00K | 428.00K | 1.11M | -934.00K | -415.00K | 42.00K | 196.00K | 77.56K | -3.85M | -340.74K | 908.30K | -5.44M |
| Other Non-Cash Items | 21.95M | -5.43M | 39.00K | 242.00K | -72.00K | -2.59M | -539.00K | -382.00K | -190.00K | -2.32M | 427.57K | 657.13K | -13.61M | 392.62K |
| Deferred Income Tax | -2.85M | n/a | 1.78M | 5.66M | -4.17M | n/a | -291.00K | -258.00K | -1.32M | -3.35M | -630.29K | -1.65M | 12.72M | 2.25M |
| Change in Working Capital | 15.20M | 1.24M | -540.00K | -1.29M | 4.32M | -1.71M | 2.65M | 411.00K | 154.00K | 151.00K | -3.59M | 48.45K | 1.39M | 4.37M |
| Operating Cash Flow | -22.61M | -26.24M | -23.57M | -23.21M | -22.67M | -24.19M | -20.55M | -14.51M | -14.17M | -14.48M | -20.23M | -20.11M | -11.22M | 11.46M |
| Capital Expenditures | -297.00K | -316.00K | -97.00K | n/a | -73.00K | -10.22M | -4.24M | -55.00K | -2.72M | -178.48K | -117.16K | -176.39K | -284.81K | -660.94K |
| Acquisitions | -1.56M | -4.14K | 38.13K | n/a | 6.00K | 1.50M | -1.00M | 3.00K | -202.00K | -5.39K | -861.16K | 191.12K | -34.94K | -138.67K |
| Purchase of Investments | -47.59M | -44.00M | -78.00M | -33.50M | -43.55M | -26.50M | -44.02M | -32.98M | -63.13M | -53.02M | -37.15M | -3.43M | -16.67M | -8.04M |
| Sales Maturities Of Investments | 49.33M | 48.32M | 39.87M | 50.17M | 48.88M | 44.77M | 33.33M | 42.33M | 50.25M | 35.03M | 31.57M | 17.35M | 7.17M | 381.34K |
| Other Investing Acitivies | 1.56M | 4.14K | -38.13K | 16.67M | -6.00K | 9.73M | -15.59M | -3.00K | 202.00K | 5.39K | 861.16K | -191.12K | -50.45K | 138.67K |
| Investing Cash Flow | 1.44M | 4.01M | -38.22M | 16.67M | 5.26M | 9.55M | -15.93M | 9.30M | -15.60M | -18.17M | -5.69M | 13.74M | -9.87M | -8.32M |
| Debt Repayment | -1.99M | 6.07M | -3.57M | -3.36M | -1.10M | 9.22M | -93.00K | -93.00K | 436.00K | n/a | -37.00K | -77.79K | -80.92K | 198.00K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 2.96M | 5.00K | 10.91M | 1.98M | 1K | 3.88M | n/a | n/a | n/a | -2.38M | 3.00K | -494.69K | -4.87K | 17.61K |
| Financial Cash Flow | 15.06M | 20.44M | 57.75M | 17.87M | 19.19M | 13.10M | 38.68M | 2.09M | 29.49M | 30.26M | 15.85M | 15.77M | -80.66K | 215.62K |
| Net Cash Flow | -6.33M | -2.40M | -3.84M | 11.53M | 1.89M | -1.71M | 2.64M | -3.08M | -246.00K | -2.15M | -10.75M | 9.44M | -20.67M | 1.65M |
| Free Cash Flow | -22.91M | -26.56M | -23.67M | -23.21M | -22.74M | -34.41M | -24.79M | -14.57M | -16.89M | -14.66M | -20.35M | -20.29M | -11.51M | 10.80M |